Godawari Pow & IspIron & Steel Products | GPIL Q1FY27: Revenue up 32% YoY, margins soften on input costs; Vision 2030 outlined8 Aug 2026Order Pipeline Disclosed | -3.2% +1.9% +4.5% | ₹207 | 13,493 Cr | 15.8vs 17.0 | 17.0% | +32.3% |
Unimech Aerospace N MFGAerospace & Defense | Q1 FY27: Revenue up 71% YoY, EBITDA margin 36.5%, signs FACC supply deal8 Aug 2026Order Pipeline Disclosed×2 | -1.8% +3.3% +8.1% | ₹1,741 | 8,854 Cr | 123.0vs 74.4 | 10.3% | +70.9% |
Lemon Tree HotelsHotels & Resorts | Lemon Tree Hotels Q1 FY27 Investor Presentation - Revenue Up 9% YoY7 Aug 2026Order Pipeline Disclosed | -1.2% -2.6% -4.7% | ₹111 | 8,757 Cr | 37.2vs 27.5 | 9.2% | +9.1% |
PowericaHeavy Electrical Equipment | Powerica Q1 FY27: Revenue up 27% YoY, PAT up 27%, DG order book INR 1,700 cr7 Aug 2026Order Pipeline Disclosed×2 | -0.3% +1.1% +9.2% | ₹586 | 7,416 Cr | 33.2vs 36.5 | 10.2% | — |
Dr Agarwals Health CareHospital | Dr. Agarwal's Q1 FY27 earnings call transcript filed7 Aug 2026Order Pipeline Disclosed | -0.7% -9.0% -8.0% | ₹474 | 15,023 Cr | 101.0vs 42.7 | 7.1% | +26.0% |
Maharashtra SeamlessIron & Steel Products | Q1FY27 earnings: PAT up, margins improve, net cash Rs 3,838 cr7 Aug 2026Order Pipeline Disclosed | +1.4% +4.8% +22.5% | ₹651 | 8,718 Cr | 11.8vs 17.0 | 13.0% | -4.7% |
Transport Corpn of IndiaLogistics Solution Provider | TCI Q1 FY27 earnings call transcript filed with exchanges7 Aug 2026Order Pipeline Disclosed | +1.7% -0.3% -6.7% | ₹881 | 6,784 Cr | 14.8vs 15.9 | 14.4% | +9.6% |
JK Lakshmi CementCement & Cement Products | JK Lakshmi Cement Q1 FY27 call flags cost pressure, outlines capex plan7 Aug 2026Order Pipeline Disclosed | -2.5% -1.4% -10.4% | ₹466 | 5,789 Cr | 15.7vs 29.9 | 8.4% | +9.4% |
Inox WindHeavy Electrical Equipment | Inox Wind Q1 FY27 Results: Revenue Rs 872cr, Order Book 4.4 GW7 Aug 2026Order Pipeline Disclosed | -4.6% -5.1% -2.1% | ₹63.75 | 11,018 Cr | 26.4vs 36.5 | 8.0% | -1.5% |
Computer Age MNGT SerDepositories Clearing Houses and Other Intermediaries | CAMS Q1 FY27: EBITDA up 18% YoY at INR183 cr, margin guidance of 1-1.5% expansion7 Aug 2026Order Pipeline Disclosed×2 | +0.4% -3.9% -9.3% | ₹671 | 16,664 Cr | 17.4 | 43.8% | +11.5% |
Ratnamani Met & TubIron & Steel Products | Q1 FY27 Investor Presentation: Weak Standalone, Strong Subsidiaries7 Aug 2026Order Pipeline Disclosed | -3.5% +1.3% +13.5% | ₹2,471 | 17,322 Cr | 40.0vs 17.0 | 15.6% | -15.6% |
Alivus Life SciencesPharmaceuticals | Q1 FY27 earnings call transcript filed, margins beat, FY27 guidance reaffirmed7 Aug 2026Order Pipeline Disclosed×2 | +4.0% +5.9% +4.7% | ₹1,343 | 16,482 Cr | 27.3vs 31.6 | 21.6% | +6.4% |
Clean Max Enviro EN SolPower Generation | Q1 FY27 earnings call: revenue doubles, PAT INR 55 cr, FY28 EBITDA guidance INR 3,000 cr7 Aug 2026Order Pipeline Disclosed×3 | -4.7% -8.3% +1.6% | ₹1,350 | 15,825 Cr | 111.1vs 20.6 | 0.7% | — |
Intellect Design ArenaComputers - Software & Consulting | Intellect Design Arena Q1 FY27 Earnings Call Transcript7 Aug 2026Order Pipeline Disclosed×2 | +0.9% -4.0% -5.6% | ₹572 | 8,019 Cr | 22.4vs 15.8 | 13.4% | +20.4% |
Blue Jet HealthcarePharmaceuticals | Blue Jet Healthcare Q1 FY27 earnings call transcript filed7 Aug 2026Order Pipeline Disclosed | +0.7% +2.9% -3.0% | ₹525 | 9,104 Cr | 38.7vs 31.6 | 23.5% | -17.4% |
Chambal FertilizersFertilizers | Chambal Fertilisers Q1 FY27: EBITDA up 12% on better margins, revenue dips 12%6 Aug 2026Order Pipeline Disclosed | -1.6% -5.2% -8.8% | ₹385 | 15,411 Cr | 8.0vs 10.8 | 20.7% | -11.8% |
Leela Palaces HotelHotels & Resorts | Q1 FY27 earnings call transcript: revenue up 28%, EBITDA up 41%6 Aug 2026Order Pipeline Disclosed×2 | -1.2% +1.5% +5.9% | ₹591 | 19,750 Cr | 32.6vs 27.5 | 5.9% | +28.1% |
Hindustan Construction CoCivil Construction | HCC shares Q1 FY27 analyst presentation; margin dips, debt pre-payment planned6 Aug 2026Order Pipeline Disclosed | -6.1% -6.9% +9.3% | ₹19.09 | 5,001 Cr | 25.1vs 14.5 | 5.4% | -9.0% |
Lloyds Engg WorkIndustrial Products | Lloyds Engg Q1FY27: Revenue up 139%, PAT up 127%, Order book Rs 88.6K Cr6 Aug 2026Order Pipeline Disclosed | +6.4% +5.0% -6.4% | ₹95.78 | 14,093 Cr | 55.4vs 28.5 | 11.5% | +142.9% |
Rategain Travel TechnComputers - Software & Consulting | RateGain Q1 FY27 revenue jumps 188% post Sojern deal, EBITDA margin at 24.6%6 Aug 2026Order Pipeline Disclosed | -2.9% -2.9% -12.2% | ₹842 | 9,962 Cr | 41.0vs 15.8 | 8.7% | +187.6% |
IndegeneHealthcare Research Analytics & Technology | Indegene Q1 FY27: Revenue up 39.7% YoY, margins to recover by Q46 Aug 2026Order Pipeline Disclosed | +3.3% +4.3% +11.2% | ₹594 | 14,295 Cr | 35.6 | 14.9% | +39.7% |
Clean Science & TechSpecialty Chemicals | Clean Science Q1 FY27 call: record sales, HALS ramps up, new deals6 Aug 2026Order Pipeline Disclosed | +3.7% +9.0% +9.9% | ₹806 | 8,562 Cr | 36.8vs 24.7 | 19.1% | +10.5% |
KPIT TechnologiesComputers - Software & Consulting | KPIT FY26 Annual Report filed; Revenue up 4.8% to USD 724.8 Mn5 Aug 2026Order Pipeline Disclosed×3 | +1.1% -2.2% -10.0% | ₹482 | 13,137 Cr | 22.5vs 15.8 | 20.5% | +8.8% |
PCBL ChemicalCarbon Black | PCBL Q1 FY27 Earnings Transcript: Revenue up 17%, PAT up 65%5 Aug 2026Order Pipeline Disclosed×2 | -2.7% -4.6% -4.1% | ₹320 | 12,580 Cr | 48.1 | 3.4% | +17.0% |
Shadowfax TechnologiesLogistics Solution Provider | Q1 FY27 earnings call: revenue growth guidance raised to 38-40%5 Aug 2026Order Pipeline Disclosed | -1.4% +6.0% +2.8% | ₹287 | 16,783 Cr | 104.3vs 15.9 | 5.7% | — |
Railtel Corp of IndOther Telecom Services | RailTel Q1 FY27: Revenue up 20%, order book at 11,747 cr5 Aug 2026Order Pipeline Disclosed | -0.2% -3.3% -6.6% | ₹251 | 8,059 Cr | 39.9 | 13.9% | +24.1% |
KalpataruResidential Commercial Projects | Kalpataru Q1 FY27 earnings call transcript filed5 Aug 2026Order Pipeline Disclosed×2 | +0.4% -1.3% -3.9% | ₹264 | 5,430 Cr | 43.2vs 21.0 | 1.4% | +6.5% |
DCM ShriramDiversified | DCM Shriram Q1 FY27 earnings call transcript filed5 Aug 2026Order Pipeline Disclosed×2 | +0.4% +0.8% -0.1% | ₹967 | 15,150 Cr | 10.5vs 12.1 | 9.5% | +9.5% |
Avalon TechnologiesOther Electrical Equipment | Avalon Technologies Q1 FY27 results: Revenue up 49.8%, PAT up 145% YoY4 Aug 2026Order Pipeline Disclosed | -1.2% +7.4% +30.1% | ₹2,343 | 15,655 Cr | 117.0vs 25.0 | 20.0% | +49.8% |
BirlasoftComputers - Software & Consulting | Birlasoft Files Q1 FY27 Earnings Call Transcript4 Aug 2026Order Pipeline Disclosed×2 | -1.1% -3.4% -12.6% | ₹275 | 7,676 Cr | 13.4vs 15.8 | 18.1% | +7.3% |
Triveni Engg. & Inds.Sugar | Triveni Engineering Q1 FY27 Earnings Call Transcript Filed4 Aug 2026Order Pipeline Disclosed×2 | -4.5% +9.1% +13.0% | ₹240 | 5,289 Cr | 18.8vs 16.1 | 9.4% | -0.2% |
Optiemus InfracomTelecom - Equipment & Accessories | Optiemus Q1 FY27: Revenue doubles to ₹883 cr; FY29 target ₹6,000 cr4 Aug 2026Order Pipeline Disclosed | -6.3% -8.6% -8.6% | ₹821 | 7,281 Cr | 99.4 | 7.0% | +102.8% |
PricolAuto Components & Equipments | Pricol Q1FY27 concall: revenue up 23%, margins under pressure, demerger on track4 Aug 2026Order Pipeline Disclosed | -1.4% +2.9% +1.0% | ₹659 | 8,032 Cr | 30.0vs 26.8 | 23.6% | +23.5% |
Morepen Lab.Pharmaceuticals | Morepen Labs Q1 FY27 Investor Presentation filed4 Aug 2026Order Pipeline Disclosed | +33.6% +41.6% +97.9% | ₹139 | 7,641 Cr | 54.5vs 31.6 | 8.3% | +34.1% |
Laxmi Organic IndusSpecialty Chemicals | Laxmi Organic Q1 FY27 Transcript: Revenue Up 40%, EBITDA Up 272% YoY4 Aug 2026Order Pipeline Disclosed | +0.8% -3.2% -4.5% | ₹185 | 5,132 Cr | 40.8vs 24.7 | 3.5% | +39.8% |
Jain Resource RecyclingDiversified Metals | Q1FY27 Investor Presentation: Revenue Rs 2,725 Cr, Up 76% YoY3 Aug 2026Order Pipeline Disclosed | -7.5% -13.4% -20.3% | ₹284 | 9,792 Cr | 26.6 | 29.5% | +75.9% |
Usha MartinIron & Steel Products | Usha Martin Q1 FY27 earnings call transcript filed3 Aug 2026Order Pipeline Disclosed | +4.2% -0.5% +2.5% | ₹505 | 15,403 Cr | 30.3vs 17.0 | 17.7% | +16.4% |
Strides Pharma SciPharmaceuticals | Strides Pharma Q1 FY27: 13% revenue growth, EBITDA margin steady at 18.2%3 Aug 2026Order Pipeline Disclosed | -5.5% -3.9% +3.3% | ₹1,085 | 10,000 Cr | 16.3vs 31.6 | 16.6% | +13.0% |
Tanfac IndustriesCommodity Chemicals | Tanfac Q1 FY27 earnings call transcript filed3 Aug 2026Order Pipeline Disclosed×2 | +1.5% +6.5% +0.2% | ₹3,197 | 6,378 Cr | 52.2vs 19.1 | 24.3% | +12.3% |
Senores PharmaceuticalsPharmaceuticals | Senores Pharma Q1FY27 transcript: 36% revenue growth, 87% EBITDA jump; FY27 PAT guidance 50-60%3 Aug 2026Order Pipeline Disclosed×2 | +3.9% +14.6% +9.6% | ₹1,334 | 6,142 Cr | 47.0vs 31.6 | 13.5% | +30.6% |